Skip to main content
. 2021 Jun 9;12:673302. doi: 10.3389/fphar.2021.673302

FIGURE 2.

FIGURE 2

Kaplan–Meier estimates of cumulative percentages of patients with TTR ≥60% in (A) original cohort and (B) propensity score matching (PSM) cohort.TTR, time in therapeutic range; GC, general clinic; PPCC, physician–pharmacist collaborative clinic; Blue line represents the probability in the GC group and red line represents the probability in the PPCC group.